These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2891231)

  • 21. [Possible diagnosis of Pseudomonas aeruginosa infection by an immunoenzyme method using pyoimmunogen as the antigen].
    Severtsova MK; Dubova VG; Getmanova MA; Temper RM
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Apr; (4):63-6. PubMed ID: 3137744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of Clostridium perfringens alpha toxin by enzyme-linked immunosorbent assay.
    Naylor RD; Martin PK; Barker LT
    Res Vet Sci; 1997; 63(1):101-2. PubMed ID: 9368967
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The prevention of experimental Clostridium novyi and Cl. perfringens gas gangrene in high-velocity missile wounds by active immunisation.
    Boyd NA; Thomson RO; Walker PD
    J Med Microbiol; 1972 Nov; 5(4):467-72. PubMed ID: 4345766
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of continuous sub-culturing on infectivity of Clostridium perfringens ATCC13124 in mouse gas gangrene model.
    Kumar RB; Alam SI
    Folia Microbiol (Praha); 2017 Jul; 62(4):343-353. PubMed ID: 28213749
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clindamycin-resistant Clostridium perfringens cellulitis.
    Khanna N
    J Tissue Viability; 2008 Aug; 17(3):95-7. PubMed ID: 18558488
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pathomorphologic changes in animals with experimental gas infection immunized with Cl. perfringens and oedematiens toxoids].
    Pushkarev AA; Sunargulov TS; Mel'nikov VN
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Jan; (1):132-3. PubMed ID: 4375917
    [No Abstract]   [Full Text] [Related]  

  • 27. Lipoproteins from Clostridium perfringens and their protective efficacy in mouse model.
    Dwivedi P; Alam SI; Kumar O; Kumar RB
    Infect Genet Evol; 2015 Aug; 34():434-43. PubMed ID: 26027922
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Specific antibody against Clostridium perfringens type A enterotoxin in Chinese on Taiwan.
    Tsai CC; Jong YM; Hsieh YH; Hodge FA
    Taiwan Yi Xue Hui Za Zhi; 1976 Jun; 75(6):323-7. PubMed ID: 185320
    [No Abstract]   [Full Text] [Related]  

  • 29. Diagnosis and management of clostridium perfringens sepsis and uterine gas gangrene.
    Halpin TF; Molinari JA
    Obstet Gynecol Surv; 2002 Jan; 57(1):53-7. PubMed ID: 11773832
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Morphological erythrocyte changes due to alpha and theta hemolysin due to gas gangrene toxin].
    HABERMANN E; POHLMANN G
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1959; 237():487-94. PubMed ID: 13830669
    [No Abstract]   [Full Text] [Related]  

  • 31. An immunoassay for the rapid and specific detection of three sialidase-producing clostridia causing gas gangrene.
    Roggentin T; Kleineidam RG; Majewski DM; Tirpitz D; Roggentin P; Schauer R
    J Immunol Methods; 1993 Jan; 157(1-2):125-33. PubMed ID: 8423355
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stress proteins of Clostridium perfringens type A immunoreact with antiserum from rabbits infected with gas gangrene.
    Heredia N; Aréchiga E; Labbé R; García S
    Int Microbiol; 2003 Dec; 6(4):259-61. PubMed ID: 12910385
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early diagnosis of clostridial gas gangrene using sialidase antibodies.
    Roggentin P; Gutschker-Gdaniec GH; Hobrecht R; Schauer R
    Clin Chim Acta; 1988 Apr; 173(3):251-62. PubMed ID: 2898309
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quality assurance of C. perfringens epsilon toxoid vaccines--ELISA versus mouse neutralisation test.
    Rosskopf-Streicher U; Volkers P; Noeske K; Werner E
    ALTEX; 2004; 21 Suppl 3():65-9. PubMed ID: 15057410
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effectiveness of gas gangrene anatoxins in revaccination by the aerosol method].
    Gefen NE; Egorova NB; Miroshnichenko IV; Efremova VN; Serdtsev AI
    Voen Med Zh; 1975 Feb; (2):47-8. PubMed ID: 166512
    [No Abstract]   [Full Text] [Related]  

  • 36. Automated systems in viral diagnosis.
    Sever JL
    Curr Top Microbiol Immunol; 1983; 104():57-75. PubMed ID: 6347536
    [No Abstract]   [Full Text] [Related]  

  • 37. [Detection of toxins of Clostridium perfringens type A in infected animals by using the ELISA test].
    Nowakowska M; Bartoszcze M; Matras J
    Med Dosw Mikrobiol; 1989; 41(3-4):166-9. PubMed ID: 2561810
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The functional activity of wound mononuclear phagocytosing cells in revaccination with a Clostridium perfringens anatoxin].
    Sergeeva TI; Zaĭtseva LG; Chirikova EV; Vasil'eva EI; Babaĭtseva VA; Kornienko OIu
    Zh Mikrobiol Epidemiol Immunobiol; 1994; (6):63-5. PubMed ID: 7879544
    [No Abstract]   [Full Text] [Related]  

  • 39. Antibody against Clostridium perfringens type A enterotoxin in healthy beef cattle and human populations in Brazil.
    Brant PC; Riemann HP; Franti CE; Torres-Anjel MJ
    Rev Latinoam Microbiol; 1978; 20(3):139-42. PubMed ID: 225770
    [No Abstract]   [Full Text] [Related]  

  • 40. Fulminant septic shock due to Clostridium perfringens skin and soft tissue infection eight years after liver transplantation.
    Juntermanns B; Radunz S; Heuer M; Vernadakis S; Reis H; Gallinat A; Treckmann J; Kaiser G; Paul A; Saner F
    Ann Transplant; 2011; 16(3):143-6. PubMed ID: 21959524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.